Method for the treatment of glaucoma and ocular hypertension with prostaglandin analogues without melanogenic side effect

摘要

Prostaglandin-induced increased pigmentation of the iris can be avoided, or significantly reduced, when using a selective EP₂ prostanoid receptor agonist in combination with an alpha-adrenergic agonist. Methods and compositions for the treatment of glaucoma and ocular hypertension are described.